Clinical Trials Logo

Aphasia clinical trials

View clinical trials related to Aphasia.

Filter by:

NCT ID: NCT05525377 Completed - Alzheimer Disease Clinical Trials

Better Living With Non-memory-led Dementia

Start date: June 21, 2022
Phase: N/A
Study type: Interventional

This is a feasibility study on the effects of an online-based training and education programme for carers of people with posterior cortical atrophy (PCA), primary progressive aphasia (PPA) and behavioural-variant frontotemporal dementia (bvFTD).

NCT ID: NCT05520528 Active, not recruiting - Stroke Clinical Trials

Impact of Group Participation on Adults With Aphasia

Start date: September 6, 2022
Phase: N/A
Study type: Interventional

The purpose of the study is to examine the impact of group participation on adults with aphasia. Participants will complete a standard pre-and post-assessment of language abilities (speech, comprehension, reading, and/or writing). Then participants will attend 90-minute weekly reading group sessions during an academic semester.

NCT ID: NCT05512884 Recruiting - Aphasia Clinical Trials

Speeded Anomia Treatment in Chronic Post-stroke Aphasia

Start date: January 15, 2023
Phase: N/A
Study type: Interventional

The main aim of the study is to investigate the effect of a novel, speeded anomia therapy (Conroy et al., 2018) in a large population of patients with chronic post-stroke aphasia. The treatment will be delivered via a web application (QuickWord).

NCT ID: NCT05502822 Recruiting - Clinical trials for Functional Magnetic Resonance Imaging

High Definition Transcranial Alternating Current Stimulation (HD-tACS) for Post-stroke Aphasia

Start date: March 18, 2021
Phase: N/A
Study type: Interventional

To investigate the intervention effect of high definition transcranial alternating current stimulation(HD-tACS) in chronic post-stroke aphasia and its underlying neural mechanism by MRI.

NCT ID: NCT05483556 Recruiting - Stroke Clinical Trials

tDCS Effects on Brain Plasticity in Aphasia Treatment

Start date: November 1, 2021
Phase: N/A
Study type: Interventional

The efficacy of conventional speech therapy alone for aphasia recovery is inconclusive. The prospective study will monitor the effects of combined language therapy and tDCS through structural and functional MRI.

NCT ID: NCT05471570 Completed - Aphasia Clinical Trials

Effect of Anodal Transcranial Direct Current Stimulation (tDCS) Over the Right-hemisphere on Picture Naming in Chronic Aphasia

Start date: January 1, 2017
Phase: N/A
Study type: Interventional

There are two opposing hypotheses, namely the interference and laterality-shift hypotheses, regarding the role of the right hemisphere (RH) in language recovery following a left hemisphere damage. Transcranial direct current stimulation (tDCS) has received increasing attention as a potential complement to behavioural therapy. This preliminary study aimed to examine the effect of excitatory (anodal) stimulation of right inferior frontal gyrus (IFG) on naming abilities of chronic people with aphasia (PWA) to examine the compensatory versus interference role of RH in language recovery, and to confirm the application of tDCS does not induce adverse effects on other cognitive and language functions.

NCT ID: NCT05455463 Completed - Aphasia, Acquired Clinical Trials

Effect of Participation in Virtual Exercise Sessions in Persons With Aphasia

Start date: September 17, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to test the feasibility and acceptability of an online exercise program for community-dwelling individuals with aphasia, a language disorder resulting from brain damage. Physical activity, language, cognitive, and quality of life outcomes will be collected to assess potential effectiveness.

NCT ID: NCT05450341 Recruiting - Aphasia Clinical Trials

Efficacy of Low-frequency rTMS in Aphasia

Start date: July 18, 2022
Phase: N/A
Study type: Interventional

In a randomized controlled trial, efficacy of low-frequency, inhibitory rTMS will be examined in rehabilitation of acquired aphasia. Two cortical sites will be targeted: Right-hemispheric homologues of Broca's and Wernicke's areas. In addition to cognitive screening prior to onset of rTMS, language assessments will be conducted before, during and after the intervention. An eyetracking-while-listening experiment will also be conducted before and after the intervention to investigate morphosyntactic processing.

NCT ID: NCT05443633 Recruiting - Clinical trials for Primary Progressive Aphasia

Enhancing Language Function in Aphasia

Start date: October 30, 2022
Phase: N/A
Study type: Interventional

Aphasia is an acquired impairment of language, that commonly results from damage to language areas in the brain (typically the left side of the brain). This impairment is seen in many aspects of language, including understanding, speaking, reading and writing. It is estimated that about 2 million individuals are currently living with aphasia in the United States. Further, about 200,000 Americans acquire aphasia every year (National Aphasia Association, 2020). Aphasia poses significant impact on the affected individuals and their families. Behavioral treatments that target language deficits have been shown to enhance overall communication skills and life satisfaction among individuals with aphasia. Although there is evidence that suggests that treatment is efficacious for individuals with aphasia, the extent of improvement long-term coupled with the neural patterns among those individuals are largely unknown. The current study aims to investigate the efficacy of language-based treatment and its corresponding neural patterns.

NCT ID: NCT05437159 Recruiting - Clinical trials for Stuttering, Developmental

Investigating Speech Sequencing in Neurotypical Speakers and Persons With Disordered Speech

Start date: April 3, 2023
Phase: N/A
Study type: Interventional

Persistent developmental stuttering affects more than three million people in the United States, and it can have profound adverse effects on quality of life. Despite its prevalence and negative impact, stuttering has resisted explanation and effective treatment, due in large part to a poor understanding of the neural processing impairments underlying the disorder. The overall goal of this study is to improve understanding of the brain mechanisms involved in speech motor planning and how these are disrupted in neurogenic speech disorders, like stuttering. The investigators will do this through an integrated combination of experiments that involve speech production, functional MRI, and non-invasive brain stimulation. The study is designed to test hypotheses regarding the brain processes involved in learning and initiating new speech sound sequences and how those processes compare in persons with persistent developmental stuttering and those with typical speech development. These processes will be studied in both adults and children. Additionally, these processes will be investigated in patients with neurodegenerative speech disorders (primary progressive aphasia) to further inform the investigators understanding of the neural mechanisms that support speech motor sequence learning. Together these experiments will result in an improved account of the brain mechanisms underlying speech production in fluent speakers and individuals who stutter, thereby paving the way for the development of new therapies and technologies for addressing this disorder.